None listed
Conditions
Interventions
None listed
Sponsors
Pusan National University Korean Medicine Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Patients who are diagnosed with lung cancer and are scheduled to undergo first chemotherapy - Adult patients over 19 years of age - Patients who agreed to the purpose of the study and wrote a written consent - Patients who are able to fill out questionnaires on their own or under the care of a caregiver/researcher
Exclusion criteria
Exclusion criteria: - pregnant woman - Patients who are undergoing treatment for underlying diseases such as malignancies other than lung cancer, chronic kidney disease, chronic liver disease, severe cardiovascular disease, severe infectious disease, complicated diabetes mellitus - Patients whose cognitive dysfunction cannot fill out questionnaires when participating in the study - Patients who participated in other clinical studies for the past 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of EORTC QLQ-C30 score of Global health status, Functional scales(Physical, Role, Emotional, Cognitive, Social Function) and Symptom scales(Fatigue, Nausea and vomiting, Pain, Dyspnea, Insomnia, Appetite loss, Constipation, Diarrhea, Financial difficulties);Change of EORTC QLQ- LC13 score of sypmtoms(Dyspnea, cough, Haemoptysis, Sore mouth, Dysphagia, Peripheral neuropathy, Alopecia, Pain in chest, Pain in arm or shoulder, Pain in other parts) | — |
Secondary
| Measure | Time frame |
|---|---|
| Experience of using Korean medicine or CAM before and after diagnosis of lung cancer, Plan of using Korean medicine or CAM with chemotherapy, reasons for concurrent using/not using Korean medicine or CAM with chemotherapy | — |
Countries
Korea, Republic of
Contacts
Public ContactMinna Hong
Pusan National University Korean Medicine Hospital
Outcome results
None listed